Recombinant SARS-CoV-2 bivalent (Alpha/Beta variant) S-trimer protein vaccine (SinoCelltech)

重组新冠病毒2价（Alpha/Beta变异株）S三聚体蛋白疫苗（神州细胞）

Report date: 2025/06/12 17:08:47

Base Information

Drug NameRecombinant SARS-CoV-2 bivalent (Alpha/Beta variant) S-trimer protein vaccine (SinoCelltech)
Drug Alias NameSCTV-01-C
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Arab EmiratesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSinoCelltech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinoCelltech Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A